Richard Popp

Dr. Popp is Professor of Medicine-Emeritus at Stanford University and Director of Ethics & Policy, for the Program in Biodesign.

He received his undergraduate and medical degrees from Johns Hopkins University where he performed his internship and residency. He did further clinical and research training in Cardiology at Indiana University Medical Center and at Stanford, returning to the Stanford faculty in 1971 after military service. Dr. Popp began his career as an "invasive" cardiologist but he has focused his research on developing non-invasive methods for medical diagnosis and therapy. He has authored over 280 publications and has been a pioneer in the development of ultrasound in cardiology. He worked with the Hewlett Packard laboratories to build their first phased array two dimensional ultrasonic imaging instrument. He remains the Principal Medical Consultant to Agilent Laboratories, after spending the academic year in 1992-1993 on sabbatical in the Hewlett Packard Laboratories.

Dr. Popp was President of the American College of Cardiology (ACC) 1997-98 and has been a trustee of the ACC for many years. He has been President of the American Society of Echocardiography and the Association of University Cardiologists. He is the previous Chairman of the American Board of Internal Medicine's (ABIM) Cardiovascular Diseases Subspecialty Board and has been on the Executive Committee and the Board of Governors of the ABIM. He is a member of the American Society for Clinical Investigation and the Association of American Physicians.

Dr. Popp maintains a continuing interest in technology development for improved patient care. The diffusion of technology and new information into clinical practice is a special area of interest. He has made significant contributions to the continuous improvement of ultrasonic diagnostic methods by several companies in areas including two-dimensional and three-dimensional echocardiography, Doppler ultrasound, color flow imaging, transesophageal and contrast echocardiography. He was one of the first to employ intravascular ultrasonic imaging. He currently oversees the Section on Ethics and Policy within the Biodesign Program, one of the elements of the Stanford Bio-X Program.